OpGen, Inc. (OPGN)
NASDAQ: OPGN · IEX Real-Time Price · USD
3.026
-0.004 (-0.13%)
At close: Jul 19, 2024, 4:00 PM
2.867
-0.159 (-5.25%)
Pre-market: Jul 22, 2024, 8:53 AM EDT
OpGen Employees
As of December 31, 2022, OpGen had 100 total employees, including 85 full-time and 15 part-time employees. The number of employees increased by 1 or 1.01% compared to the previous year.
Employees
100
Change (1Y)
1
Growth (1Y)
1.01%
Revenue / Employee
$26,730
Profits / Employee
-$266,591
Market Cap
4.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Pharma Holdings | 231 |
Regional Health Properties | 114 |
iSpecimen | 53 |
Sintx Technologies | 43 |
Genprex | 26 |
Bio-Path Holdings | 10 |
Palisade Bio | 9 |
MyMD Pharmaceuticals | 6 |
OPGN News
- 2 months ago - OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q - GlobeNewsWire
- 2 months ago - OpGen Announced 1-for-10 Reverse Stock Split - GlobeNewsWire
- 2 months ago - OpGen Provides Update on Business Operations and Strategic Opportunities - GlobeNewsWire
- 3 months ago - OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K - GlobeNewsWire
- 4 months ago - OpGen Announces Acquisition of Preferred Stock by David Lazar - GlobeNewsWire
- 8 months ago - OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 10 months ago - OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds - GlobeNewsWire
- 1 year ago - OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire